<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02711514</url>
  </required_header>
  <id_info>
    <org_study_id>JR1000R</org_study_id>
    <nct_id>NCT02711514</nct_id>
  </id_info>
  <brief_title>Femoral Artery Crossover Rates in 1000 Consecutive Radial Cath Labs Procedures.</brief_title>
  <acronym>FACR</acronym>
  <official_title>Femoral Artery Crossover Rates of 1000 Consecutive Radial (or Ulnar) Artery Procedures in the Cardiac Cath Lab for Diagnostic Cardiac Catheterizations and/or Percutaneous Coronary Interventions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Miami Cardiac and Vascular Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Miami Cardiac and Vascular Institute</source>
  <brief_summary>
    <textblock>
      Comparison of Crossover rates of Radial Cardiac Catheterizations and/or PCIs into femoral vs&#xD;
      published literature&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A retrospective review of 1000 consecutive Radial or Ulnar Cardiac Catheterizations and/or&#xD;
      Percutaneous Coronary Interventions performed in our Institute by one single operator could&#xD;
      provide us with the cross over rates to femoral interventions. In this manner these rates&#xD;
      could be compared to the published rates of other institutions benchmarking our techniques&#xD;
      with the outcomes for such interventions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    COVID-19&#xD;
  </why_stopped>
  <start_date type="Actual">December 2014</start_date>
  <completion_date type="Actual">July 2020</completion_date>
  <primary_completion_date type="Actual">July 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Crossover rate from Radial to Femoral access</measure>
    <time_frame>1 year</time_frame>
    <description>How often do you start a Cath on the Radial Artery and for any reason, have to switch to Femoral Artery.</description>
  </primary_outcome>
  <enrollment type="Actual">10</enrollment>
  <condition>Retrospective Review</condition>
  <eligibility>
    <study_pop>
      <textblock>
        1000 Consecutive Patients who underwent Radial (or Ulnar) Artery Procedures in the Cardiac&#xD;
        Cath Lab for Diagnostic Cardiac Catheterizations and/or Percutaneous Coronary&#xD;
        Interventions.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients coming to the emergency room requiring Diagnostic Cardiac Catheterizations&#xD;
             and/or Percutaneous Coronary Interventions&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cardiac Tamponade&#xD;
&#xD;
          -  Cardiogenic Shock&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ramon Quesada, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Director Structural Heart BHSF</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Miami Cardiac and Vascular Institute</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33176</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>March 14, 2016</study_first_submitted>
  <study_first_submitted_qc>March 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2016</study_first_posted>
  <last_update_submitted>February 18, 2021</last_update_submitted>
  <last_update_submitted_qc>February 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Miami Cardiac and Vascular Institute</investigator_affiliation>
    <investigator_full_name>Raul Herrera, MD</investigator_full_name>
    <investigator_title>Director Cardiac and Vascular Institute</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

